FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment

FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.

Read the full story at FDA press releases (opens in a new tab)

Headline and summary from FDA press releases; the full story is on the publisher's site. Nothing here is investment advice.